Stephen Parker

Stephen Parker

Vermögen: 184 194 $ am 31.08.2026

67 Jahre
Health Technology
Finance
Commercial Services

Profil

Dr. Stephen B. Parker is a Non-Executive Chairman at Biodexa Pharmaceuticals Plc, a Non-Executive Chairman at Drishti Discoveries Ltd., an Executive Chairman at Sareum Holdings Plc and a Partner at Celtic Pharma Management LP.
He is on the Board of Directors at Eternans Ltd., Sp2 Asset Management Ltd., Sareum Ltd. and Sp2 Consulting Ltd. Dr. Parker was previously employed as a Non-Executive Chairman by MGC Pharmaceuticals Ltd., a Chairman by Liverpool Chirochem Ltd., an Independent Non-Executive Director by Silence Therapeutics Plc, a Partner by Beehive Capital LLP, a Non-Executive Chairman by Physiomics Plc, a Principal by Celtic Pharma Holdings Advisors LLP, a Chief Financial Officer by Oxford GlycoSciences Plc, a Chairman by Ah Animal Healthcare Ltd., a Principal by Apax Partners LLP, a Principal by Barings Plc, a Head-Partner Network, Research & Development by Bedford Royalties Ltd., a Non-Executive Director by Gammadelta Therapeutics Ltd., a Consultant by PA Consulting Group Holdings Ltd., a Co-Founder by UK Stem Cell Foundation, and a Principal by Warburg Group Plc.
He also served on the board at Albucasis Ltd., Celtic Pharma Development UK Plc, Celtic Pharma GP Ltd., Houlihan Lokey Advisory Ltd., Novacta Biosystems Ltd., PBB Devices Ltd., Xenova Group Plc and Xenova Ltd. He received his undergraduate degree from the University of East Anglia, an MBA from Bayes Business School and a doctorate degree from the University of Oxford.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
26.03.2025 405’045 ( 0.29% ) 184 194 $ 31.08.2026
12.03.2026 0 ( -.--% ) - $ 31.08.2026

Aktive Positionen von Stephen Parker

UnternehmenPositionBeginn
BIODEXA PHARMACEUTICALS PLC Vorsitzender 20.06.2022
SAREUM HOLDINGS PLC Vorsitzender 17.05.2016
Sp2 Consulting Ltd.
Direktor/Vorstandsmitglied -
Eternans Ltd.
Direktor/Vorstandsmitglied 01.07.2019
Vorsitzender 01.01.2021
Direktor/Vorstandsmitglied -
Sp2 Asset Management Ltd.
Direktor/Vorstandsmitglied 01.09.2018
Private Equity Investor 01.04.2005

Ehemalige bekannte Positionen von Stephen Parker

UnternehmenPositionEnde
ARGENT BIOPHARMA LIMITED Vorsitzender 01.12.2023
░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Stephen Parker im Detail an

Ausbildung von Stephen Parker

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

63

Beziehungen ersten Grades

33

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen33

Commercial Services

Miscellaneous

Finance

Health Technology

Finance

Commercial Services

Consumer Services

Commercial Services

Finance

Finance

Health Technology

Finance

Commercial Services

Consumer Services

Finance

Finance

Consumer Services

Miscellaneous

Health Technology

Finance

Health Technology

Retail Trade

Celtic Pharma GP Ltd.

Xenova Ltd.

Commercial Services

Health Technology

Health Technology

Sp2 Consulting Ltd.

Health Technology

Health Technology

Eternans Ltd.

Health Technology

Sp2 Asset Management Ltd.

  1. Börse
  2. Insiders
  3. Stephen Parker
LETZTE CHANCE | -40 %: Die besten Tools exklusiv für Abonnenten - Ihr Schlüssel zu den Top-Investitionen der Zukunft!
T
:
:
PROFITIEREN SIE JETZT